Tag: Biotech and Pharmaceuticals

Eli Lilly reaches $2.75 billion deal with Insilico to bring AI-developed drugs to the global market

The price of menstrual products is skyrocketing from inflation, tariffs

How CNBC Cures is bringing rare disease stories to a national audience

FDA approves higher dose version of weight loss drug Wegovy as Novo Nordisk tries to win back market share

Eli Lilly’s next-generation obesity drug retatrutide clears first late-stage diabetes trial

Healthy Returns: Stopping GLP-1s raises risk of heart attack, stroke and death, study says

FDA approves psoriasis pill from J&J that rivals shots Tremfya, Skyrizi

Vertex passes key test in quest to treat kidney diseases

FDA approves leucovorin as first drug for rare genetic disorder, after touting it as autism treatment

Hims & Hers shares surge 50% after Novo Nordisk drops patent infringement case over compounded weight loss drugs